CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![clinical-trial-tech-ai-GettyImages-2226144959]( "State Of Clinical Trial Technology: The AI Inflection Point")
State Of Clinical Trial Technology: The AI Inflection PointDigital maturity gaps are widening in clinical research. Connected workflows speed insights and execution, while manual processes leave organizations increasingly behind.
-
![Machine Learning-AI-GettyImages-2236865789]( "The Next Competitive Advantage In Clinical Trials Is Execution Intelligence")
The Next Competitive Advantage In Clinical Trials Is Execution IntelligenceAI fails in clinical trials when decision-making is messy. To win, sponsors must fix their "execution blind spot" by structuring how work happens, letting AI turn hidden patterns into strategy.
-
![GettyImages-2213157127-drug-formulation-discovery-pipette-liquid-vial]( "Expedite Drug Development With An Integrated CDMO-CRO Model")
Expedite Drug Development With An Integrated CDMO-CRO ModelFrom optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.
-
![esource-data-GettyImages-2198084779]( "Sponsor-Provided Source Templates: Your Questions Answered")
Sponsor-Provided Source Templates: Your Questions AnsweredSee how centralized eSource improves trial operations through faster startup, better data quality, and real‑time protocol guidance. An expert Q&A offers practical tips for sponsors, sites, and CROs.
-
![Futuristic data-GettyImages-1325172964]( "Navigating The Post-Capture Era Of Clinical Trials")
Navigating The Post-Capture Era Of Clinical TrialsLiberating data through structured workflow management is the key to evolving clinical trials from a series of administrative hurdles into a high-speed engine for medical innovation.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Changing The Clinical Feasibility Game With AI1/22/2026
AI is only as good as the data it’s built upon. Our customized AI platforms are constructed on a foundation of trustworthy, carefully curated data to produce detailed, expert-driven responses.
-
Drilling Down On Diversity And Feasibility12/8/2025
A mid-sized contract research organization (CRO) sought help with writing clinical trial diversity action plans and assessing feasibility for therapeutic areas outside its usual scope.
-
Accelerating Clinical Data Review With Traceable Workflows12/3/2025
Clinical data review needs centralized access and traceable workflows. Leveraging AI-automation and real-time collaboration drives faster, better-informed decisions and reduced compliance risk.
-
Rescuing Data Integrity: A Swift Transition And Quality Transformation11/14/2025
Uncover how this collaboration supported timely progress toward key study milestones, enabling smoother execution and more dependable output across data management and statistical activities.
-
Effect Of Etrasimod On Immune Cell Subsets In Colonic Tissue9/25/2025
Etrasimod selectively modulates S1P receptors to reduce inflammation and immune cell trafficking to the gut, showing promise in treating moderate to severe ulcerative colitis.
CENTRAL LABORATORIES PRODUCTS & SERVICES
Patients shouldn’t have to jump through hoops. Discover an innovative portal that lets them handle travel and reimbursement directly—securely, simply, and without extra calls to the site.
The Revvity Signals Software Risk-Based Monitoring Solution is the most effective way to leverage data-driven insights to optimize site performance while improving patient safety.
Signals Clinical streamlines clinical data workflows, reducing the time spent preparing data for analytics. Its comprehensive platform enables the rapid delivery of clinical insights that inform both clinical and operational study decisions.
Enables secure real-time document review, co-authoring, and redaction in order to shorten the document review process by up to 65%.
Accelerate Medical Writing Without Compromising Accuracy or Compliance
In the fast-paced world of clinical research, the ability to produce, review, and finalize high-quality documents—on time and with full regulatory compliance—is non-negotiable. Ideagen Document Review (formerly known as PleaseReview) is the trusted collaboration and co-authoring platform that enables clinical teams to streamline document reviews, reduce version chaos, and ensure traceable, auditable feedback across the board.
A centralized command center for patient randomization and drug supply management—built for today’s complex clinical trials.
CENTRAL LABORATORIES SOLUTIONS
- Trial Results Summaries
- Standardized Data In One Place
- Financial Scenario Planning
- Driving Success In Dermatology Drug Development
- Modernize Clinical Research With Continuous Digital Data
- Medidata Research Alliance: Partnerships For Medical Progress
- Signant SmartSignals® Advisory
- A Proven Approach To Assessment Consistency And Endpoint Data Quality
- Bring Your EDC Study In-House
- Unify Workflows And Accelerate Execution From Protocol To Submission
VIDEOS
- Keeping Your Trials In Motion And Use AI Where It Makes Sense
- Streamline Data Entry With EHR-To-EDC Software
- Revolutionize Data Access With An AI Powered Custom Listing Generator
- How AI-Enhanced CAPA Systems Cut Non-Conformances By Targeting Root Causes
- The Industry’s First And Only Unified Platform For RWE Generation
NEWS
- Altasciences Announces Chris Perkin Appointed To Board Of Directors; Marie-Hélène Raigneau Appointed Chief Executive Officer
- AI Agent Enhances Principal Investigator Oversight Of eCOA Data
- Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes
- Univo IRB And The Patient View Announce Partnership
- Avance Clinical Launches Diversity In STEM Scholarships Across Australia And North America
- Lindus Health And Quotient Sciences Partner To Accelerate Drug Development From First-In-Human To Pivotal Trials
- Integrating Lyft Healthcare As An Affordable On-Demand Transportation Provider For Clinical Trial Participants: A Move Towards Enhanced Patient Experience
- Yoncare s.r.o. Partners With Block Clinical Inc. To Deliver EU-Centric Clinical Trial Participant Travel And Payment Services In Europe
- Block Clinical Discusses Patient Travel Support With Panel Members
- Quotient Sciences And Intrepid Labs Form Strategic Partnership To Accelerate AI-Guided Formulation Development
- One App To Simplify The Clinical Trial Journey
- Avance Clinical Showcases Early Phase Expertise And The Australian Advantage For EU Biotechs At BIO-Europe Vienna
- Meet Avance Clinical At SCOPE Summit 2026 In Orlando, Florida
- Signant Health Appoints Internationally Recognized Cognitive Assessment Expert John Harrison To Further Advance Innovation In CNS Clinical Trials
- Avance Clinical Launches Renal And Cardiometabolic Center Of Excellence To Optimize Patient Recruitment To Elevate Study Success
- Avance Clinical Unveils Dedicated CNS Center Of Excellence For Expert Clinical Trial Services In Neuroscience
- Suvoda Expands EU Patient Travel with Bolt Partnership
- Avance Clinical Launches Dedicated Center Of Excellence To Accelerate Early Phase Biotech Trials
- Castor Catalyst: Launching Self-Driving Clinical Trials With Google Cloud AI
- Almac Trial Coordinator Launched In $48 Million Investment To Advance Integrated eClinical Technologies
- Quotient Sciences And Biorasi Partner To Accelerate Early Phase Clinical Trials To Patient Proof-Of-Concept
- Biorasi Unveils New Website To Drive Sponsor Success With Biotech-Centric Strategies And Modular CRO Solutions
- Suvoda And Greenphire Complete Brand Integration With Unified Website And Social Media Presence
- Avance Clinical Accelerates Time To Pivotal Milestones For More Than 700 Emerging Biotechs
- Avance Clinical Attends Reception Welcoming Australia's US Ambassador To North Carolina Governor's Executive Mansion In Raleigh, N.C.
- Avance Clinical Strengthens Korea Focus: Seoul Meeting Highlights Growth, Partnerships, And Regional Collaboration
- "Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns
- ISPOR Real-World Evidence Summit 28-30 September 2025, Tokyo, Japan
- Ametris Expands Collaborative Research Project To Investigate Digital Measures Of Physical Function For Drug Development in Obesity
- Quotient Sciences And CPI To Accelerate RNA Drug Development With Joint Venture